Back to all studies
Active Not RecruitingNCT05732298

Theta Burst Stimulation in Pharmacologically Untreated Patients as Sole Antidepressant Treatment

This study is active but not recruiting. It focuses on depression and currently lists study information in Germany.

DepressionDeviceFrom 18 Years to 70 Years
Need help deciding?

Ask HopeStage to review this study with me

Loading the security check...
Study ID: NCT05732298. We help you review the study, but cannot decide medical eligibility.
In plain English

Key information made simple

This study is looking at whether intermittend theta burst stimulation (iTBS) can help people with Depression. Participants receive a study treatment and complete follow-up visits and assessments. Taking part may give some people access to intermittend theta burst stimulation (iTBS), but direct benefit is not guaranteed.

What to expect

Your next step

The official record suggests in-person participation through a research setting, with sites including Department of Psychiatry and Psychotherapy in Regensburg. Participation appears to involve a study treatment together with follow-up visits and routine safety or progress checks. The main fit is usually meeting the main study requirements, while common reasons not to take part include major medical issues that could make participation unsuitable and pregnancy or breastfeeding. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: February 27, 2023
Recruitment status
Active Not Recruiting
Estimated enrollment
Not clearly listed
Sponsor
University of Regensburg
Sponsor type
University
Study type
Device
Intervention type
Device / app / digital / technology
Study phase
Not clearly listed
Locations
Germany
Age range
From 18 Years to 70 Years
Official registry ID
NCT05732298
Official source
Official registry link

Want help reviewing this study?

Loading the security check...
Study ID: NCT05732298. We help you review the study, but cannot decide medical eligibility.
Why this study may matter

Why this study may matter

This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.

In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in Germany.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring brain stimulation for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a device, app, or technology?

This appears to be a device / app / digital / technology study. The phase is not clearly listed in the public registry. Phase is mostly relevant for medication studies and some device studies. For this study, it may be more useful to look at what is required, the duration, visits, and eligibility criteria.

Who might this study be for?

This study may concern people with depression; age range: From 18 Years to 70 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to use a device, app, or digital tool for a defined period. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What should I check about data, monitoring, alerts, and daily use?

If the study uses a device, app, or digital tool, check what data is collected, who can access it, how often you need to use it, and what happens if the tool detects a concerning signal. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by University of Regensburg, which appears to be a university. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The registry indicates that the study is active but not currently recruiting. This usually means participants may already be involved, but new participants may not be accepted.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Theta Burst Stimulation in Pharmacologically Untreated Patients as. — Depression Clinical Trial | HopeStage